LRINEC Score
Calculate the LRINEC score (Laboratory Risk Indicator for Necrotizing Fasciitis) from 6 lab parameters. Free medical scoring tool with risk categories and component breakdown.
About This Calculator
The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score is a validated clinical scoring system designed to help healthcare professionals distinguish necrotizing fasciitis from other severe soft tissue infections. First described by Wong et al. in 2004, this evidence-based tool uses six routine laboratory parameters to provide an objective risk assessment that supports clinical decision-making.
The LRINEC score evaluates six lab parameters: C-reactive protein (CRP), total white blood cell count, hemoglobin, serum sodium, serum creatinine, and serum glucose. Each parameter is scored based on specific threshold values, with higher scores indicating greater likelihood of necrotizing fasciitis. The total score ranges from 0 to 13, corresponding to low (≤5), medium (6-7), or high (≥8) risk categories.
Necrotizing fasciitis, often called flesh-eating disease, is a rare but rapidly progressive infection that affects the deep soft tissues. Early recognition is critical as the condition can progress to sepsis and multi-organ failure within hours. The LRINEC score should be used alongside clinical examination, imaging studies, and when indicated, surgical exploration for definitive diagnosis. This free calculator provides instant results with a component breakdown and visual chart for quick interpretation.
Regional Notes
The LRINEC score uses universal laboratory thresholds and applies globally regardless of country. Lab value units (mg/dL for creatinine and glucose, g/dL for hemoglobin, mmol/L for sodium, mg/L for CRP, and cells/µL for WBC) are standardized internationally. Healthcare professionals in India, the US, the UK, and worldwide can use this calculator with their local lab results.
Frequently Asked Questions
What is the LRINEC score?
LRINEC stands for Laboratory Risk Indicator for Necrotizing Fasciitis. It is a validated scoring system that uses six routine laboratory tests (C-reactive protein, white blood cell count, hemoglobin, serum sodium, serum creatinine, and serum glucose) to differentiate necrotizing fasciitis from other soft tissue infections.
How is the LRINEC score calculated?
The LRINEC score assigns points based on threshold values of six lab parameters: CRP >150 mg/L scores 4 points; WBC 15–25 scores 1, >25 scores 2; hemoglobin 11–13.5 scores 1, <11 scores 2; sodium <135 mmol/L scores 2; creatinine >1.6 mg/dL scores 2; glucose >180 mg/dL scores 1. The total score ranges from 0 to 13.
What does a high LRINEC score mean?
A LRINEC score of 8 or higher indicates a high probability (>75%) of necrotizing fasciitis and warrants urgent surgical consultation. Scores of 6–7 indicate medium risk (50–75%), and scores of 5 or less indicate low risk (<50%). The LRINEC score should be used alongside clinical assessment.
Is the LRINEC score a definitive diagnosis?
No, the LRINEC score is a screening tool that helps estimate the probability of necrotizing fasciitis. It is not a definitive diagnostic test. A definitive diagnosis requires clinical evaluation, imaging studies, and surgical exploration with tissue biopsy when indicated.
What are the early signs of necrotizing fasciitis?
Early signs of necrotizing fasciitis include severe body pain out of proportion to visible injury, fever, chills, nausea, and diarrhea. Later symptoms include redness and swelling, skin discoloration and blisters, unstable blood flow, low blood pressure, tissue death (necrosis), and sepsis.
How common is necrotizing fasciitis?
Necrotizing fasciitis is a rare but serious condition estimated to affect 0.3 to 15 people per 100,000. It can develop from any injury that allows bacteria to enter the skin or deeper tissues. People with diabetes or weakened immune systems are at higher risk.
What is the treatment for necrotizing fasciitis?
Treatment for necrotizing fasciitis requires urgent surgical debridement to remove all dead and infected tissue, broad-spectrum intravenous antibiotics, fluid resuscitation, and supportive care. Early diagnosis and treatment are critical for survival.